aitiologic

Aitiologic is a precision diagnostics company pioneering the next generation of liquid biopsy. Its patented aitios®platform integrates artificial intelligence with multi-modal DNA profiling to decode previously inaccessible molecular signals from blood – enabling early, non-invasive detection of treatable diseases. Beginning with prenatal care, Aitiologic is developing an AI-powered blood test to detect hundreds of treatable fetal conditions – before symptoms arise and ahead of conventional diagnostics – giving every child the best possible start to a healthy life. With broader applications spanning maternal health and oncology, Aitiologic is redefining how and when we detect disease – transforming early insight into timely intervention and better outcomes at every stage of life.